Prof. Lili Song MD PhD, is Distinguished Research Professor at the Institute of Science and Technology for Brain-Inspired Intelligence, Fudan University, Shanghai, China. She has been a neurologist and focused on clinical research in recent decade. Her research interest is in the treatment and prevention of acute stroke, in particular of blood pressure management around stroke. She has been leading several large-scale clinical trials in stroke area including INTERACT3, INTERACT4, ENCHANTED-2/MT, LATE-MT, CHAIN and ASPIRING as co-PI, co-investigator, or Project lead. She is also sitting on Steering Committee or Data Safety Monitoring Board for several large clinical trials. She has published more than 70 publications on high impact clinical journals including NEJM and The Lancet. She has successfully awarded an MRC joint funding in 2019 as well as MRFF grants in 2022 and 2023. She is a regular reviewer for several high-ranking clinical journals including Lancet, JAMA, Lancet Neurology, Stroke, Cerebrovascular Diseases, etc. She was authored or co-authored Review, Editorial or Commentary for JAMA, Lancet Neurology, JAMA Neurology, Stroke, etc. She was a visiting fellow at The University of Sydney in 2012-2013. She has been selected one of 2018 Emerging Leaders by the World Heart Foundation.